Literature DB >> 12387869

Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1.

Jill M Grenier1, Lin Wang, Gulam A Manji, Waan Jeng Huang, Amal Al-Garawi, Roxanne Kelly, Adam Carlson, Sarah Merriam, Jose M Lora, Michael Briskin, Peter S DiStefano, John Bertin.   

Abstract

PYRIN-containing Apaf-1-like proteins (PYPAFs) are a recently identified family of proteins thought to function in apoptotic and inflammatory signaling pathways. PYPAF1 and PYPAF7 proteins have been found to assemble with the PYRIN-CARD protein ASC and coordinate the activation of NF-kappaB and pro-caspase-1. To determine if other PYPAF family members function in pro-inflammatory signaling pathways, we screened five other PYPAF proteins (PYPAF2, PYPAF3, PYPAF4, PYPAF5 and PYPAF6) for their ability to activate NF-kappaB and pro-caspase-1. Co-expression of PYPAF5 with ASC results in a synergistic activation of NF-kappaB and the recruitment of PYPAF5 to punctate structures in the cytoplasm. The expression of PYPAF5 is highly restricted to granulocytes and T-cells, indicating a role for this protein in inflammatory signaling. In contrast, PYPAF2, PYPAF3, PYPAF4 and PYPAF6 failed to colocalize with ASC and activate NF-kappaB. PYPAF5 also synergistically activated caspase-1-dependent cytokine processing when co-expressed with ASC. These findings suggest that PYPAF5 functions in immune cells to coordinate the transduction of pro-inflammatory signals to the activation of NF-kappaB and pro-caspase-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387869     DOI: 10.1016/s0014-5793(02)03416-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  107 in total

1.  Homology modeling provides insights into the binding mode of the PAAD/DAPIN/pyrin domain, a fourth member of the CARD/DD/DED domain family.

Authors:  Tong Liu; Ana Rojas; Yuzhen Ye; Adam Godzik
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

Review 2.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 3.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

4.  Three-dimensional structure of the NLRP7 pyrin domain: insight into pyrin-pyrin-mediated effector domain signaling in innate immunity.

Authors:  Anderson S Pinheiro; Martina Proell; Clarissa Eibl; Rebecca Page; Robert Schwarzenbacher; Wolfgang Peti
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

Review 5.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 6.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 7.  Inflammasomes in intestinal inflammation and cancer.

Authors:  Grace Y Chen; Gabriel Núñez
Journal:  Gastroenterology       Date:  2011-10-15       Impact factor: 22.682

Review 8.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 9.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

10.  The NLR gene family: a standard nomenclature.

Authors:  Jenny P-Y Ting; Ruth C Lovering; Emad S Alnemri; John Bertin; Jeremy M Boss; Beckley K Davis; Richard A Flavell; Stephen E Girardin; Adam Godzik; Jonathan A Harton; Hal M Hoffman; Jean-Pierre Hugot; Naohiro Inohara; Alex Mackenzie; Lois J Maltais; Gabriel Nunez; Yasunori Ogura; Luc A Otten; Dana Philpott; John C Reed; Walter Reith; Stefan Schreiber; Viktor Steimle; Peter A Ward
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.